- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Immunomodulation by entinostat in renal cell carcinoma patients receiving high dose interleukin 2: a multicenter, single-arm, phase 1/2 trial (NCI-CTEP#7870)
September 25, 2017
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial
September 25, 2017
Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases
September 25, 2017
Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma
September 25, 2017
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma
September 22, 2017
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
September 22, 2017
Association between coffee consumption and risk of renal cell carcinoma: A Meta-analysis
September 22, 2017
Emerging Immunotherapy in Advanced Renal Cell Carcinoma
September 21, 2017
European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the elderly
September 21, 2017
Systemic treatment of renal cell cancer: A comprehensive review
September 21, 2017
When Partial Nephrectomy is Unsuccessful: Understanding the Reasons for Conversion from Robotic Partial to Radical Nephrectomy at a Tertiary Referral Center
September 20, 2017
[Combination Therapy of Immune Checkpoint Inhibitors]
September 20, 2017
[Overall survival and renal function after partial and radical nephrectomy in malignant localized renal tumors.]
September 20, 2017
New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far?
September 20, 2017
Sarcomatoid Renal Cell Carcinoma: The Apple Doesn't Fall Far From the Tree
September 20, 2017
Management of Atypical Renal Cell Carcinomas
September 19, 2017